𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibodies to single stranded DNA: A diagnostic aid in chronic hepatitis b virus infections

✍ Scribed by Dr. Victor M. Villarejos; Jaime Serra C.; Kirsten A. Visoná; Carlos E. Eduarte


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
348 KB
Volume
4
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Serial determinations of titers of binding antibodies to single stranded DNA were performed over a period of three years in 43 type B hepatitis patients with persisting HBsAg who had either developed chronic hepatitis or were asymptomatic carriers. Patients with histopathological diagnosis of chronic active or chronic persistent hepatitis, with or without clinical symptoms, showed high titers of anti-DNA throughout the course of the disease, whereas in most of these patients the serum alanine transaminase and bilirubin levels fluctuated widely and were often normal; in such cases the elevation of anti-DNA was frequently the only positive sign present. On the other hand anti-DNA titers were within the normal range in chronic asymptomatic HBsAg carriers who showed no histopathological or biochemical changes. Anti-DNA determinations are proposed as a reliable diagnostic aid to supplement current procedures for assessment of the disease status during the course of chronic hepatitis B virus infections.


📜 SIMILAR VOLUMES


Antibodies to single-stranded DNA: An ai
✍ Dr. Victor M. Villarejos; Pierre C. Arquembourg; Kirsten A. Visoná; Alvaro Gutié 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

## Abstract In clinical and subclinical viral hepatitis a significant increase of antibodies to single‐stranded DNA revealed the prepatent stage of the disease before any elevation of serum transaminases. In type A hepatitis, a rise in anti‐DNA titers was detectable one to two weeks before onset of

Diagnostic significance of antibodies to
✍ Michael Kann; Heinrich G. Köchel; Angela Uy; Reiner Thomssen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 766 KB

## Abstract The prevalence and time course of the occurrence of antibodies to the hepatitis B virus polymerase (anti‐HBpol) were investigated in acutely and in chronically HBV‐infected individuals by using recombinant HBpol protein for Western blot analysis. One group consisted of 19 patients who w

Antibodies to single-stranded and double
✍ A J Czaja; S A Morshed; S Parveen; M Nishioka 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

dsDNA were shown in 64% of patients with autoimmune To determine the significance of antibodies to singlehepatitis, 46% with cryptogenic hepatitis, and 43% with stranded (anti-ssDNA) and double-stranded DNA (antichronic hepatitis B. 8 Tsuchiya and colleagues, using an ELISA dsDNA) in antinuclear ant

Immunoglobulin M and A antibodies to hep
✍ George K. K. Lau; Richard Lesniewski; Rhonda G. Johnson; Gary L. Davis; Johnson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## Abstract To determine the prevalence and clinical significance of IgM and IgA antibody to hepatitis C virus (HCV) core antigen in chronic HCV infection, sera from 47 patients were tested for immunoglobulin class M (IgM) and immunoglobulin A (IgA) antibody to HCV core antigen by solid‐phase enzym

Association of concurrent hepatitis B su
✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t

Is there a meaningful serum hepatitis B
✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Ioannis S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

The diagnosis of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B indicating therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA >2,000 IU/mL. We evaluated the severity of liver histology and the presence of histological indication for treatment in patients with H